Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „subjects“
Suchtreffer
Begriffe & Kennungen
Akeega · 4.5 · CYP2C8 substrates Abiraterone is an inhibitor of CYP2C8. In a clinical study in healthy subjects, the AUC of p
Eintrag öffnenAkeega · 4.5 · In a separate clinical study in healthy subjects, co-administration of ketoconazole, a strong inhibitor of CYP
Eintrag öffnenAlkindi · 4.8 · A total of 30 healthy (but dexamethasone-suppressed) adult male subjects in two phase 1 studies and 24 paediat
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · The vast majority of subjects receiving up to 4 full years of treatment with orlistat in clinical studies had
Eintrag öffnenAltuvoct · 4.8 · Adverse drug reactions (ADRs) (summarized in Table 2) were reported in 111 (40.1%) of the 277 subjects treated
Eintrag öffnenAlunbrig · 4.5 · In healthy subjects, coadministration of multiple 600 mg daily doses of rifampicin, a strong CYP3A inducer, wi
Eintrag öffnenAlunbrig · 4.5 · In vitro studies demonstrated that brigatinib is a substrate of CYP2C8. In healthy subjects, coadministration
Eintrag öffnenAlunbrig · 4.5 · In vitro studies demonstrated that brigatinib is a substrate of CYP3A4/5. In healthy subjects, coadministratio
Eintrag öffnenAmbirix · 4.3 · As with other vaccines, the administration of Ambirix should be postponed in subjects suffering from acute sev
Eintrag öffnenAmbirix · 4.8 · Clinical trials involved the administration of 2029 doses of Ambirix to 1027 subjects from 1 year up to and in
Eintrag öffnenAmeluz · 4.8 · The incidence of adverse reactions in 624 subjects exposed to photodynamic therapy with Ameluz in pivotal clin
Eintrag öffnenAmyvid · 4.8 · The safety profile of Amyvid is based on its administrations to 26,979 subjects in clinical trials.
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenAripiprazole Accord · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAripiprazole Accord · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAripiprazole Sandoz · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAripiprazole Sandoz · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAripiprazole Zentiva · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAripiprazole Zentiva · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnen